Corsair Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Corsair Pharma?

Corsair Pharma has 5 investors including Primavera Capital Group And Junson Capital.

Q: When was the last funding round for Corsair Pharma?

Corsair Pharma closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Corsair Pharma raised to date?

Corsair Pharma has raised obfuscated.

Overview

Corsair Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Corsair Pharma

CB Rank

40621

Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.

Founded

obfuscation

Private

Series B

Sunnyvale, California, United States

11-50

www.corsairpharma.com/

Dietary Supplements

Manufacturing

Therapeutics

Funding Rounds

Series B

OBF

obfuscation

Key People

George Mahaffey: Chief Executive Officer
Past Role: MiNDERA Corporation, President & CEO
Garrett Vygantas: Chief Business Officer
Past Role: Jump Capital, Partner

Details

Legal Name

Corsair Pharma

Operating Status

Active

Company Type

For Profit

Contact Email

info@corsairpharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Corsair Pharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Transdermal Treprostinil Prodrug Patch

A transdermal patch delivering an inactive prodrug that converts to treprostinil in the liver to treat pulmonary arterial hypertension (PAH).

Research & Development

Corsair Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B
obfuscated obfuscation	Series B - Corsair Pharma	5	obfuscated obfuscation	New Rhein	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Primavera Capital Group	—	Series B - Corsair Pharma	—
Primavera Capital Group	—	Series B - Corsair Pharma	—
Primavera Capital Group	—	Series B - Corsair Pharma	—
Primavera Capital Group	—	Series B - Corsair Pharma	—
Primavera Capital Group	—	Series B - Corsair Pharma	—